News
Moderna’s New Flu Shot Shows Strong Results in Older Adults
The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA. Copyright © 2025 HealthDay. All rights reserved.
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...
The US FDA has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.
PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the ...
Myocarditis, when the heart muscle gets inflamed, can make it harder for the heart to pump blood possibly causing chest pain, ...
The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...
The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback